DE69229269T2 - Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik - Google Patents

Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik

Info

Publication number
DE69229269T2
DE69229269T2 DE69229269T DE69229269T DE69229269T2 DE 69229269 T2 DE69229269 T2 DE 69229269T2 DE 69229269 T DE69229269 T DE 69229269T DE 69229269 T DE69229269 T DE 69229269T DE 69229269 T2 DE69229269 T2 DE 69229269T2
Authority
DE
Germany
Prior art keywords
pct
iid6
cytochrome
hepatitis
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69229269T
Other languages
English (en)
Other versions
DE69229269D1 (de
Inventor
Fernando Alvarez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of DE69229269D1 publication Critical patent/DE69229269D1/de
Publication of DE69229269T2 publication Critical patent/DE69229269T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0077—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with a reduced iron-sulfur protein as one donor (1.14.15)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
DE69229269T 1991-06-17 1992-06-16 Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik Expired - Fee Related DE69229269T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9107363A FR2677653A1 (fr) 1991-06-17 1991-06-17 Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune.
PCT/FR1992/000539 WO1992022656A1 (fr) 1991-06-17 1992-06-16 Fragments peptidiques issus du cytochrome humain p450 iid6, anticorps anti-fragments peptidiques et leurs applications dans le diagnostic de l'hepatite auto-immune

Publications (2)

Publication Number Publication Date
DE69229269D1 DE69229269D1 (de) 1999-07-01
DE69229269T2 true DE69229269T2 (de) 1999-11-11

Family

ID=9413909

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229269T Expired - Fee Related DE69229269T2 (de) 1991-06-17 1992-06-16 Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik

Country Status (9)

Country Link
US (1) US5830667A (de)
EP (1) EP0589993B1 (de)
JP (1) JP3284240B2 (de)
AT (1) ATE180512T1 (de)
CA (1) CA2111672A1 (de)
DE (1) DE69229269T2 (de)
ES (1) ES2133320T3 (de)
FR (1) FR2677653A1 (de)
WO (1) WO1992022656A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2748812B1 (fr) * 1996-05-20 1999-06-18 Sumitomo Chemical Co Trousse de diagnostic et procede pour determiner la concentration d'un cytochrome p450
DE19805815C1 (de) 1998-02-13 1999-11-11 Ansgar W Lohse Diagnostikum zum Erkennen der autoimmunen Hepatitis
DE19930933B4 (de) * 1998-07-10 2005-05-25 Imtec Immundiagnostika Gmbh Verfahren zur Bestimmung von anti-LKM 1-Antikörpern
US6787303B1 (en) 1999-04-01 2004-09-07 Alton Ochsner Medical Foundation Identification of a novel retrovirus associated with primary sclerosing cholangitis and autoimmune hepatitis
JP2004524007A (ja) * 2000-09-29 2004-08-12 メルク　エンド　カムパニー　インコーポレーテッド ヒト・シトクロムｐ４５０２ｄ６に対する抗体
US20040096874A1 (en) * 2002-04-11 2004-05-20 Third Wave Technologies, Inc. Characterization of CYP 2D6 genotypes
CN102656186A (zh) * 2008-07-17 2012-09-05 纽崔佩普有限公司 治疗剂
CN102955030A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体ana的试剂盒及其检测方法
CN102707055A (zh) * 2012-06-11 2012-10-03 郑州安图绿科生物工程有限公司 一种联合或单独检测自身免疫性肝病相关抗体的试剂盒及其检测方法
CN102955026A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体asma的试剂盒及其检测方法
CN102955027A (zh) * 2012-06-11 2013-03-06 郑州安图绿科生物工程有限公司 检测自身免疫性肝病相关抗体抗lc-1抗体的试剂盒及其检测方法
GB201507719D0 (en) * 2015-05-06 2015-06-17 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
EP3477303A1 (de) * 2017-10-27 2019-05-01 Medizinische Hochschule Hannover Methode und mittel zur diagnose von autoimmuner hepatitis mittels autoantikörper-marker

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV

Also Published As

Publication number Publication date
JP3284240B2 (ja) 2002-05-20
FR2677653A1 (fr) 1992-12-18
DE69229269D1 (de) 1999-07-01
EP0589993A1 (de) 1994-04-06
ES2133320T3 (es) 1999-09-16
ATE180512T1 (de) 1999-06-15
EP0589993B1 (de) 1999-05-26
JPH06510663A (ja) 1994-12-01
US5830667A (en) 1998-11-03
CA2111672A1 (en) 1992-12-23
WO1992022656A1 (fr) 1992-12-23
FR2677653B1 (de) 1995-04-14

Similar Documents

Publication Publication Date Title
DE69229269D1 (de) Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik
Capra et al. Light chain sequences of human IgM cold agglutinins
EP0994724A4 (de) Verfahren und zusammensetzungen zur behinderung der vervielfältigung von hiv-1
DE3750812D1 (de) Peptidzusammensetzung und Verfahren zum Nachweis von Antikörpern gegen HTLV-III.
ES2102007T3 (es) Proteinas de fusion de fragmentos de anticuerpo monomeras y dimeras.
EP2147928A3 (de) Auf Peptiden basierte Immunisierungstherapie zur Behandlung von Atherosklerose und Entwicklung von Peptid-basierten Assays zur Bestimmung von Immunreaktionen gegen oxidiertes Lipoprotein geringer Dichte
DK1476541T3 (da) Cytokin (zcytor17-ligand)
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
ATE106943T1 (de) Variante cd44-oberflächenproteine, diese kodierende dna-sequenzen, antikörper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie.
EP2258725A3 (de) Cytokinrezeptor zcytor17
DE69130457T2 (de) Peptidfragmente des env-proteins vom immunschwäche-virus der katze und ihre verwendung in der diagnostik
ATE410514T1 (de) Calciumbindende rekombinante antikörper gegen protein c
DE69529272D1 (de) MONOKLONALER ANTIKÖRPER GEGEN DAS HUMANE Mx-PROTEIN MxA
DK0687300T3 (da) LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
CA2134080A1 (en) Natural humain igm antibodies
Cohen Immune Response Corp.—Take Two
TH65071A (th) เพพไทด์ควบคุม และอนุเคราะห์ hiv แอนติเจน องค์ประกอบวัคซีนชุดสำเร็จรูปอิมมูโนแอสเสย์และวิธีการของการตรวจหาแอนติบอดีที่ถูกชักนำโดย hiv
IT1270941B (it) Peptidi di hcv e loro usi.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee